BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34386454)

  • 21. The additional value of
    Heetman JG; Paulino Pereira LJ; Kelder JC; Soeterik TFW; Wever L; Lavalaye J; van der Hoeven EJRJ; Lam MGEH; van Melick HHE; van den Bergh RCN
    Prostate; 2024 May; ():. PubMed ID: 38704755
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Berger I; Annabattula C; Lewis J; Shetty DV; Kam J; Maclean F; Arianayagam M; Canagasingham B; Ferguson R; Khadra M; Ko R; Winter M; Loh H; Varol C
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):204-211. PubMed ID: 29858591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of
    Zheng A; Wang Z; Luo L; Chang R; Gao J; Wang B; Duan X
    Front Oncol; 2023; 13():1169189. PubMed ID: 37234988
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Roberts MJ; Morton A; Donato P; Kyle S; Pattison DA; Thomas P; Coughlin G; Esler R; Dunglison N; Gardiner RA; Doi SA; Emmett L; Yaxley J
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):477-482. PubMed ID: 32696091
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Farolfi A; Ceci F; Castellucci P; Graziani T; Siepe G; Lambertini A; Schiavina R; Lodi F; Morganti AG; Fanti S
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):11-19. PubMed ID: 29905907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.
    Chinnappan S; Chandra P; Kumar JS; Chandran G; Nath S
    Indian J Nucl Med; 2021; 36(4):377-384. PubMed ID: 35125755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative evaluation of prostate cancer by
    Stasiak CES; Cardillo A; de Almeida SA; Rodrigues RS; de Castro PHR; Parente DB
    Radiol Bras; 2023; 56(4):171-178. PubMed ID: 37829589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraindividual Comparison of
    Kesch C; Vinsensia M; Radtke JP; Schlemmer HP; Heller M; Ellert E; Holland-Letz T; Duensing S; Grabe N; Afshar-Oromieh A; Wieczorek K; Schäfer M; Neels OC; Cardinale J; Kratochwil C; Hohenfellner M; Kopka K; Haberkorn U; Hadaschik BA; Giesel FL
    J Nucl Med; 2017 Nov; 58(11):1805-1810. PubMed ID: 28473595
    [No Abstract]   [Full Text] [Related]  

  • 29. Can
    Yin H; Chen M; Qiu X; Qiu L; Gao J; Li D; Fu Y; Huang H; Guo S; Zhang Q; Ai S; Wang F; Guo H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3693-3701. PubMed ID: 33813594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gallium-68-prostate-specific membrane antigen (
    van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L
    BJU Int; 2019 Jul; 124(1):62-68. PubMed ID: 30074667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical parameters and nomograms for predicting lymph node metastasis detected with
    Onal C; Ozyigit G; Oymak E; Guler OC; Hurmuz P; Tilki B; Reyhan M; Tuncel M; Akyol F
    Prostate; 2021 Jul; 81(10):648-656. PubMed ID: 33949694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy.
    Budäus L; Leyh-Bannurah SR; Salomon G; Michl U; Heinzer H; Huland H; Graefen M; Steuber T; Rosenbaum C
    Eur Urol; 2016 Mar; 69(3):393-6. PubMed ID: 26116958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations of
    Topuz ÖV; Aksu A; Erinç SR; Tamam MÖ
    Hell J Nucl Med; 2021; 24(1):60-65. PubMed ID: 33866340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of
    Hoffmann MA; Miederer M; Wieler HJ; Ruf C; Jakobs FM; Schreckenberger M
    Oncotarget; 2017 Dec; 8(67):111073-111083. PubMed ID: 29340038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients.
    Natarajan A; Agrawal A; Murthy V; Bakshi G; Joshi A; Purandare N; Shah S; Puranik A; Rangarajan V
    World J Nucl Med; 2019; 18(3):244-250. PubMed ID: 31516367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical Validation of PSMA Expression Measured by
    Woythal N; Arsenic R; Kempkensteffen C; Miller K; Janssen JC; Huang K; Makowski MR; Brenner W; Prasad V
    J Nucl Med; 2018 Feb; 59(2):238-243. PubMed ID: 28775203
    [No Abstract]   [Full Text] [Related]  

  • 37.
    Ceci F; Castellucci P; Graziani T; Farolfi A; Fonti C; Lodi F; Fanti S
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):31-39. PubMed ID: 30350010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of
    Zhang Q; Zang S; Zhang C; Fu Y; Lv X; Zhang Q; Deng Y; Zhang C; Luo R; Zhao X; Wang W; Wang F; Guo H
    J Transl Med; 2017 Nov; 15(1):230. PubMed ID: 29115970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective Evaluation of
    Gaur S; Mena E; Harmon SA; Lindenberg ML; Adler S; Ton AT; Shih JH; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Mease RC; Pomper MG; Choyke PL; Turkbey B
    AJR Am J Roentgenol; 2020 Sep; 215(3):652-659. PubMed ID: 32755168
    [No Abstract]   [Full Text] [Related]  

  • 40.
    Vinsensia M; Chyoke PL; Hadaschik B; Holland-Letz T; Moltz J; Kopka K; Rauscher I; Mier W; Schwaiger M; Haberkorn U; Mauer T; Kratochwil C; Eiber M; Giesel FL
    J Nucl Med; 2017 Dec; 58(12):1949-1955. PubMed ID: 28637799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.